We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSGZ.L Regulatory News (SGZ)

  • There is currently no data for SGZ

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

4 Jan 2018 11:05

RNS Number : 9744A
Scotgold Resources Ltd
04 January 2018
 

Scotgold Resources Limited

4 January 2018

 

Scotgold Resources Limited

 

Director/PDMR Dealings

 

Scotgold Resources Limited (AIM:SGZ) (the "Company" or "SGZ") advises that certain of the directors and a PDMR of the Company participated in the recently completed non-renounceable rights issue, at a price of £0.25 per new ordinary share, that was first announced on 13 November 2017 (the "Rights Issue"). The relevant director/PDMR participations and their resulting holdings in the Company are as follows:

 

Richard Gray (Director and Chief Executive Officer)

Holding prior to Rights Issue: 52,043 ordinary shares in SGZ

Rights Issue entitlement: 34,695 new ordinary shares in SGZ

Rights Issue shortfall shares: 10,000 new ordinary shares in SGZ

 

Following the Rights Issue, Mr Gray holds 96,738 ordinary shares in the Company, representing 0.36% (previously 0.33%) of the Company's issued share capital. In addition, Mr Gray now holds 8,939 options to acquire one share each at an exercise price of £0.40, expiring on 31 December 2019. Prior to the Rights Issue, Mr Gray held no options in the Company.

 

Christopher Sangster (Non-Executive Director)

Holding prior to Rights Issue: 182,045 ordinary shares in SGZ

Rights Issue entitlement: 20,000 new ordinary shares in SGZ

Rights Issue shortfall shares: -

 

Following the Rights Issue, Mr Sangster holds 202,045 ordinary shares in the Company, representing 0.76% (previously 1.14%) of the Company's issued share capital. In addition, Mr Sangster now holds 4,000 options to acquire one share each at an exercise price of £0.40, expiring on 31 December 2019. Prior to the Rights Issue, Mr Sangster held no options in the Company.

 

David Swan (Chief Financial Officer - PDMR)

Holding prior to Rights Issue: 10,000 ordinary shares in SGZ

Rights Issue entitlement: 6,667 new ordinary shares in SGZ

Rights Issue shortfall shares: 3,333 new ordinary shares in SGZ

 

Following the Rights Issue, Mr Swan holds 20,000 ordinary shares in the Company, representing 0.07% (previously 0.06%) of the Company's issued share capital. In addition, Mr Swan now holds 2,000 options to acquire one share each at an exercise price of £0.40, expiring on 31 December 2019. Prior to the Rights Issue, Mr Swan held no options in the Company.

 

Nat le Roux's (Non-Executive Chairman) participation in and underwriting of the Rights Issue, and his resulting holding, was disclosed in the Company's announcement dated 21 December 2017.

 

 

For further information please contact:

 

Scotgold Resources Limited Stockdale Securities Limited

Richard Gray Robert Finlay / Ed Thomas

Tel: +44 (0)1838 400 306 Tel: +44 (0)20 7601 6100

 

 

Capital Markets Consultants Smaller Company Capital Ltd

Simon Rothschild Rupert Williams

Tel +44 (0)7703 167 065 Tel: +44 (0)20 3651 2911

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHLLFEILEISIIT
Date   Source Headline
27th Dec 20237:00 amRNSCancellation - Scotgold Resources Limited
24th Nov 202310:09 amRNSAppointment of Administrators
22nd Nov 20237:00 amRNSPlanned Appointment of Administrators
8th Nov 20237:00 amRNSDirector Resignation
7th Nov 20238:00 amRNSPotential Administration Appointment
16th Oct 20237:00 amRNSUpdate On Financing Discussions
2nd Oct 202310:18 amRNSPotential Administration Appointment
29th Sep 20237:00 amRNSCorporate Update
19th Sep 20239:10 amRNSMining Review Update
11th Sep 20237:30 amRNSSuspension - Scotgold Resources Limited
11th Sep 20237:00 amRNSGeological review, mine plan and operations update
10th Jul 20237:00 amRNSProduction, Sales & Operations – Q2 2023 & H1 2023
14th Jun 20237:00 amRNSBoard Appointment
7th Jun 20237:00 amRNSInterim CEO Appointment
1st Jun 20237:00 amRNSOperational Update and Director Resignation
15th May 20237:00 amRNSSubscription and Open Offer GBP2 million raised
26th Apr 20237:00 amRNSPosting of Circular
21st Apr 20237:00 amRNSSubscription & Open Offer to raise £1.5-2.0m
5th Apr 20237:00 amRNSOfftake advance & commencement long hole stoping
31st Mar 20234:35 pmRNSPrice Monitoring Extension
30th Mar 20237:00 amRNSInterim Results
27th Mar 20234:35 pmRNSPrice Monitoring Extension
27th Mar 20232:05 pmRNSSecond Price Monitoring Extn
27th Mar 20232:00 pmRNSPrice Monitoring Extension
27th Mar 202311:06 amRNSSecond Price Monitoring Extn
27th Mar 202311:00 amRNSPrice Monitoring Extension
27th Mar 20239:05 amRNSSecond Price Monitoring Extn
27th Mar 20239:00 amRNSPrice Monitoring Extension
27th Mar 20237:00 amRNSOperations and Corporate Update
16th Feb 20237:00 amRNSResult of Retail Offer - Capital Raising of £3m
10th Feb 202311:05 amRNSSecond Price Monitoring Extn
10th Feb 202311:00 amRNSPrice Monitoring Extension
10th Feb 20239:05 amRNSSecond Price Monitoring Extn
10th Feb 20239:00 amRNSPrice Monitoring Extension
10th Feb 20237:00 amRNSResults of Capital Raise
9th Feb 20235:00 pmRNSRetail Offer
9th Feb 20234:42 pmRNSProposed Capital Raising
7th Feb 20239:00 amRNSPrice Monitoring Extension
31st Jan 20239:05 amRNSSecond Price Monitoring Extn
31st Jan 20239:00 amRNSPrice Monitoring Extension
30th Jan 20239:05 amRNSSecond Price Monitoring Extn
30th Jan 20239:00 amRNSPrice Monitoring Extension
20th Jan 20232:05 pmRNSSecond Price Monitoring Extn
20th Jan 20232:00 pmRNSPrice Monitoring Extension
19th Jan 20232:15 pmRNSResults of 2022 Annual General Meeting
19th Jan 20237:00 amRNSQ4 2022 Results and 2023 Outlook
29th Dec 20221:00 pmRNSNotice of AGM
21st Dec 20227:00 amRNSPre-close Q4 2022 – Production Update
21st Dec 20227:00 amRNSFinal Results
19th Dec 20227:00 amRNSIssue of Equity and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.